摘要
通过分析中西方医学伦理学发展道路的差异,提出我国的医学伦理审查制度虽源于西方,但因为医学伦理思想起源、人种间文化信仰及医学发展和科学模式的不同,该制度应用于我国时不能"生搬硬套",需"和而不同"的理念,并论述建设符合我国国情的伦理审查平台的现状及意义,同时强调对研究者伦理培训的重要性。
Through the analysis on different development paths of western and Chinese medical ethics,this article proposed to construct the Chinese medical ethical review system.Although the medical ethical review system was originated in western countries,due to different origins of medical ethical thoughts,different cultures and beliefs among races,as well as different medical and science development models,the application of western medical eth ical review system should not be "mechanically" used in China.The application should follow the idea of "har monization with differences." This article discussed on current status and significance of the construction of an ethical review platform which is suitable to the national conditions of China.It was also emphasized on the im portance of ethics training among researchers.
引文
1 黄春春,陈昭辉.论医学伦理委员会的意义和发展.中国医学伦理学,2005,18(2)∶62~68.
2 胡庆澧,陈仁彪,沈铭贤,等.关于设立国家生命伦理委员会的建议.中国医学伦理学,2005,18(2)∶25~26.
3 杨永杰,龚树全《.黄帝内经》.北京:线装书局,2009.
4 吴志泽.丑陋源于无知者的无敬畏.中国企业家网,2012.
5 奥古斯丁《.忏悔录》.北京:商务印书馆,1981.
6 Lura A,Christine G.A systematic review of the empirical literature evaluating IRBs:What we know and what we still need tolearn,J Empir Res Hum Res Ethics,2011,6(1)∶3~19.
7 周奕,张怀承.儒家人生观对传统医学伦理的影响.湖南师范大学社会科学学报,2013,42(2)∶47~49.
8 王思成,汪秀琴,熊宁宁.中医药临床研究伦理发展对策思考.北京中医药大学学报,2010,33(3)∶156~158.
9 刘建忠,涂远超,张馨.诌议中医药临床研究伦理审查平台建设.世界中医药,2013,8(2)∶209~211.
10 Rowanglegg A,Weier C,Gao J,et al.A comparision of journal instructions regarding institutional review board approval and conflict of interest disclosure between 1995 and 2005,Med Ethics,2009,35 ∶74~78.
11 Wu T X,Yang X Z,Zeng X X.A further investigation about ethics review status of the RCT published in Chinese journals.Abstracts of the 17th Cochrane Colloquium,2009.
12 陈竺.和而不同:生命伦理的世界性和民族性.中国医学伦理学,2006,19(4)∶3~4.